Anaplastology is a profession with deep historical roots in rehabilitative medicine. For decades anaplastologists have provided reconstructive prostheses and other custom medical devices which required extra attention to esthetic design and appearance. Advancements in patient care over the last 20 years have increased the need for a dedicated level of clinical and technical skill necessary to conduct safe and effective anaplastology practice in conjunction with emerging technologies and a higher expectation of quality care. Anaplastologists work in a variety of practice settings utilizing a unique skill set to create innovations in anaplastology and advance quality patient care.


In 1980, Walter Spohn and colleagues founded the American Anaplastology Association (AAA) at Stanford University Medical Center, in Palo Alto, California. Mr. Spohn wanted the AAA to serve as an open and inspiring "Information Exchange," welcoming all of the multidisciplinary specialists involved in prosthetic rehabilitation, and to promote coordination and communication among professionals working along different but related paths in the service of the patient.

At the recommendation of an advisory committee formed in 1997, the membership of the American Anaplastology Association voted to establish a certification board in 2000 to follow the guidelines of the National Commission for Certifying Agencies (NCCA) — the accrediting body for the agency currently known as the Institute for Credentialing Excellence (ICE). This certification board became the Board for Certification in Clinical Anaplastology (BCCA).

In 2002, the Board for Certification in Clinical Anaplastology was established as a private, autonomous organization and incorporated in the state of South Carolina as a 501(c)(3) nonprofit mutual benefit corporation.

In 2008, the American Anaplastology Association voted to change the name of the organization to the International Anaplastology Association (IAA) in recognition of the emerging global profession of clinical anaplastology.

The Board for Certification in Clinical Anaplastology and the International Anaplastology Association remain strategic partners ─ working together to achieve objectives that are mutually beneficially for the field of anaplastology.


The mission of the Board for Certification in Clinical Anaplastology is to promote and provide certification in clinical anaplastology for the enhancement of patient care and professional practice.


The vision of the Board for Certification in Clinical Anaplastology is to be recognized as the leader in clinical anaplastology credentialing.


The terms “Board for Certification in Clinical Anaplastology,” “BCCA,” “CCA,” and the BCCA logo are registered trademarks of the Board for Certification in Clinical Anaplastology. Violation of the copyright will lead to prosecution under federal copyright laws.

  • Board for Certification in Clinical Anaplastology reg. no. 4,129,996
  • BCCA reg. no. 4,090,541
  • CCA reg. no. 4,199,674
  • BCCA Certification Mark/Logo reg. no. 3,394,068

All illustrations and photographs on this website are COPYRIGHTED by the individual artists and may not be used in any way without express permission from the artist.



AMI Meeting
July 23-26, 2014

ADT Congress
September 6-8, 2014

ASO/AAO Meeting
October 17-21, 2014

AAMP Meeting
November 1-4, 2014